Mergers, acquisitions and major restructurings made Big Pharma a much smaller and leaner sector, with some 54,000 jobs lost. At least that’s better than 2009’s 61,000 layoffs.
Continue reading Which Sector Lost…
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the…
German pharmaceutical and chemical company Merck KGaA will pay $280 million to settle a U.S. Department of Justice claim brought against a former subsidiary, Dey Pharma, regarding Medicare and Medicaid reimbursements. This is t…
Stocks closed modestly mixed on light volume Friday in the last full trading week of the year, which marked the third week in a row of overall gains. While drugmakers Pfizer and Merck put a damper on the Dow, robust earnings fr…
If the extension of the Bush tax cuts triggers a market rally, as many expect, investors will likely rush in. But caution is advised: High prices can also mean high risk. Here are some tips from Alan Lancz, director of research…